Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The timing of when the gene Bmal1 is active affects aging and survival, with its absence during development, not adulthood, leading to premature aging.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

A high dietary antioxidant index may lower the risk of various diseases, but more research is needed.

Skin conditions can signal heart issues, highlighting the need for integrated care.

Eating less and exercising more, with personalized diet plans and realistic goals, can lead to weight loss and better health, but more research is needed for long-term success.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Women with PCOS are more likely to have gum disease.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.

The document concludes that managing PCOS requires a comprehensive approach, including lifestyle changes and medication, to improve symptoms and reduce health risks.

PCOS treatment should be personalized based on individual symptoms and health goals.

High testosterone increases heart disease risk in women with PCOS.

More research with diverse participants is needed to determine the effectiveness of photobiomodulation devices for hair loss treatment.

Medications for PCOS don't seem to raise heart disease risk.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Skin changes in obesity can indicate metabolic issues but aren't reliable for assessing risk or monitoring treatment.

Women with PCOS have different body composition and some metabolic differences compared to healthy women.

Women with PCOS have higher risks of heart disease, type 2 diabetes, and endometrial cancer.

Young Indians with coronary artery disease often have risk factors like smoking and central obesity, and cutaneous markers should be monitored for lifestyle changes.

COVID-19 severely affects older adults with chronic heart, lung, or metabolic diseases.

Drugs for PCOS can affect metabolism, so understanding their effects is important for managing health risks.

Women with PCOS have significant metabolic issues like insulin resistance after eating a high-fat meal.